Sutro Biopharma, Inc.
STRO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001382101
No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Sutro Biopharma, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 78 | 1 | 100 | +23 |
| Shares | 14.4M | 983 | 16.5M | +2.10M (+14.6%) |
| Value | $358.3M | $24.5K | $545.7M | +$187.4M (+52.3%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (40)
Institutions that held Sutro Biopharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (17)
Institutions that held Sutro Biopharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Ra Capital Management, L.P. | 715,307 | $17.8M |
| Adage Capital Partners GP, L.L.C. | 200,000 | $4.98M |
| Opaleye Management Inc. | 190,671 | $4.75M |
| Eversept Partners, LP | 73,161 | $1.82M |
| Burkehill Global Management, LP | 71,530 | $1.78M |
| Jane Street Group, LLC | 27,760 | $691.5K |
| StemPoint Capital LP | 23,295 | $580.3K |
| Brevan Howard Capital Management LP | 18,791 | $468.1K |
| AJU IB Investment Co., Ltd. | 17,500 | $435.9K |
| Hudson Bay Capital Management LP | 14,768 | $367.9K |
| Jump Financial, LLC | 12,385 | $308.5K |
| Omers Administration Corp | 8,700 | $216.7K |
| AQR Capital Management LLC | 8,605 | $214.4K |
| State of Tennessee, Treasury Department | 7,400 | $184.3K |
| Simplex Trading, LLC | 62 | $1.54K |
| EverSource Wealth Advisors, LLC | 19 | $473 |
| Advisory Services Network, LLC | 15 | $374 |
Not filed for Q2 2026 yet (1)
Institutions that held Sutro Biopharma, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 983 | $24.5K |